HYDROXYZINE HYDROCHLORIDE ORAL

HYDROXYZINE HYDROCHLORIDE ORAL was reported 13792 times

HYDROXYZINE HYDROCHLORIDE ORAL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 NEUROGLYCOPENIA 13 0.1182
1 NEUROBLASTOMA RECURRENT 17 0.0837
2 VASCULAR ACCESS SITE COMPLICATION 14 0.0556
3 CHEMICAL SUBMISSION 12 0.0474
4 PERIPHERAL CIRCULATORY FAILURE 15 0.0366
5 INFUSION SITE DISCHARGE 58 0.0330
6 MULTIPLE DRUG THERAPY 18 0.0239
7 DEVICE MAINTENANCE ISSUE 14 0.0238
8 VICTIM OF CRIME 26 0.0210
9 VICTIM OF CHEMICAL SUBMISSION 14 0.0209
10 PIGMENTARY MACULOPATHY 10 0.0207
11 BACTERIAL DISEASE CARRIER 15 0.0206
12 BRONCHIAL WALL THICKENING 13 0.0181
13 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 255 0.0150
14 PRODUCT NAME CONFUSION 16 0.0147
15 INFUSION SITE HAEMORRHAGE 48 0.0146
16 INFUSION SITE PRURITUS 44 0.0139
17 MAST CELL ACTIVATION SYNDROME 19 0.0135
18 INFUSION SITE URTICARIA 9 0.0134
19 INFUSION SITE WARMTH 15 0.0122
20 PERIORBITAL PAIN 10 0.0118
21 DEVICE INFUSION ISSUE 29 0.0117
22 RETINAL PIGMENTATION 9 0.0114
23 INFUSION SITE MASS 12 0.0110
24 PRODUCT ADMINISTRATION INTERRUPTED 84 0.0107
25 ENDOCRINE OPHTHALMOPATHY 9 0.0104
26 INFUSION SITE INFECTION 24 0.0103
27 DERMATITIS ATOPIC 539 0.0102
28 BRONCHIAL SECRETION RETENTION 13 0.0102
29 INFUSION SITE IRRITATION 13 0.0101
30 INFUSION SITE INDURATION 15 0.0101
31 DROWNING 10 0.0099
32 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 13 0.0096
33 SLEEP-RELATED EATING DISORDER 9 0.0096
34 INFUSION SITE PAIN 121 0.0094
35 INFUSION SITE BRUISING 20 0.0093
36 NEURODERMATITIS 34 0.0091
37 OBSTRUCTIVE SLEEP APNOEA SYNDROME 13 0.0089
38 SKIN DISCOMFORT 24 0.0089
39 EYELID PAIN 18 0.0088
40 INFUSION SITE DISCOMFORT 9 0.0087
41 CHRONIC SPONTANEOUS URTICARIA 10 0.0086
42 INFUSION SITE ERYTHEMA 72 0.0085
43 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 9 0.0085
44 GASTRIC POLYPS 18 0.0080
45 DERMATITIS CONTACT 89 0.0078
46 VASCULAR DEVICE INFECTION 35 0.0077
47 LABELLED DRUG-DRUG INTERACTION ISSUE 11 0.0076
48 ANTICHOLINERGIC SYNDROME 12 0.0075
49 DISTRIBUTIVE SHOCK 17 0.0075
50 IMPAIRED QUALITY OF LIFE 101 0.0070
51 TRANSCRIPTION MEDICATION ERROR 11 0.0070
52 INFUSION SITE SWELLING 42 0.0067
53 SKIN FISSURES 128 0.0065
54 MULTIPLE ALLERGIES 51 0.0065
55 REBOUND ATOPIC DERMATITIS 13 0.0065
56 BLOOD CHOLESTEROL DECREASED 12 0.0064
57 PRIAPISM 22 0.0064
58 SCRATCH 67 0.0063
59 HAEMOGLOBIN INCREASED 28 0.0061
60 SEASONAL ALLERGY 86 0.0061
61 SERUM FERRITIN DECREASED 10 0.0058
62 SKIN WEEPING 20 0.0056
63 GRAFT VERSUS HOST DISEASE IN SKIN 12 0.0054
64 NEPHROGENIC ANAEMIA 25 0.0054
65 INFUSION SITE REACTION 16 0.0054
66 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 14 0.0053
67 HYPERPARATHYROIDISM SECONDARY 13 0.0052
68 PEPTIC ULCER 17 0.0051
69 COMPLETED SUICIDE 425 0.0051
70 RESPIRATORY ACIDOSIS 20 0.0051
71 SKIN HAEMORRHAGE 74 0.0050
72 STUPOR 16 0.0050
73 ESSENTIAL HYPERTENSION 9 0.0049
74 HYPERVOLAEMIA 24 0.0049
75 ATRIOVENTRICULAR BLOCK FIRST DEGREE 21 0.0048
76 INSURANCE ISSUE 74 0.0048
77 HAEMATOCRIT INCREASED 11 0.0048
78 ECZEMA 252 0.0048
79 POISONING DELIBERATE 45 0.0047
80 EOSINOPHILIC OESOPHAGITIS 13 0.0047
81 MIXED LIVER INJURY 14 0.0046
82 MICTURITION DISORDER 16 0.0046
83 SKIN SWELLING 40 0.0046
84 AUTOIMMUNE THYROIDITIS 17 0.0045
85 EYELIDS PRURITUS 14 0.0045
86 PRE-EXISTING CONDITION IMPROVED 28 0.0045
87 PERIORBITAL SWELLING 25 0.0044
88 HEREDITARY ANGIOEDEMA 47 0.0044
89 EAR SWELLING 9 0.0042
90 PRODUCT DOSE OMISSION IN ERROR 120 0.0042
91 SNORING 16 0.0042
92 DISCOMFORT 257 0.0042
93 CATHETER SITE ERYTHEMA 9 0.0042
94 SPINAL CORD COMPRESSION 16 0.0041
95 DERMATITIS EXFOLIATIVE GENERALISED 14 0.0040
96 CATHETER SITE HAEMORRHAGE 10 0.0040
97 LABYRINTHITIS 10 0.0040
98 ELECTRIC SHOCK SENSATION 11 0.0039
99 HEPATIC CYTOLYSIS 49 0.0038
100 PRURITUS GENITAL 9 0.0038
101 ATRIAL TACHYCARDIA 8 0.0038
102 ATTENTION DEFICIT HYPERACTIVITY DISORDER 16 0.0038
103 TOXICITY TO VARIOUS AGENTS 638 0.0038
104 AUTONOMIC NERVOUS SYSTEM IMBALANCE 11 0.0038
105 INCORRECT DRUG ADMINISTRATION RATE 16 0.0038
106 SLEEP DISORDER 265 0.0038
107 ATYPICAL PNEUMONIA 11 0.0037
108 SKIN INFECTION 41 0.0037
109 INITIAL INSOMNIA 37 0.0036
110 CARDIO-RESPIRATORY ARREST 150 0.0036
111 POTENTIATING DRUG INTERACTION 12 0.0036
112 SKIN PLAQUE 30 0.0036
113 INFUSION SITE EXTRAVASATION 22 0.0035
114 MIOSIS 28 0.0035
115 VITAMIN D DEFICIENCY 34 0.0035
116 FEELING OF DESPAIR 16 0.0034
117 THERAPEUTIC RESPONSE SHORTENED 113 0.0034
118 BLOOD CREATINE INCREASED 15 0.0034
119 SKIN ABRASION 16 0.0034
120 EAR INFECTION 90 0.0034
121 PHARYNGEAL SWELLING 33 0.0034
122 ABDOMINAL MASS 9 0.0034
123 BRADYPNOEA 9 0.0033
124 SKIN WRINKLING 9 0.0033
125 POST-TRAUMATIC STRESS DISORDER 22 0.0033
126 BRADYKINESIA 19 0.0032
127 RESPIRATORY SYNCYTIAL VIRUS INFECTION 28 0.0032
128 HYPOALBUMINAEMIA 25 0.0032
129 DRUG ABUSE 259 0.0031
130 POISONING 39 0.0031
131 EAR DISORDER 14 0.0031
132 SPUTUM DISCOLOURED 29 0.0031
133 SWELLING OF EYELID 19 0.0030
134 PRODUCT DISTRIBUTION ISSUE 28 0.0030
135 PRURITUS 1155 0.0030
136 OBSTRUCTION 12 0.0030
137 ILLNESS 309 0.0030
138 STAPHYLOCOCCAL BACTERAEMIA 13 0.0030
139 REBOUND ACID HYPERSECRETION 9 0.0030
140 ENURESIS 12 0.0030
141 PHARYNGITIS STREPTOCOCCAL 32 0.0030
142 OCULAR DISCOMFORT 33 0.0029
143 BRAIN FOG 46 0.0029
144 RHINITIS ALLERGIC 13 0.0029
145 DERMATITIS 61 0.0029
146 PARANASAL SINUS DISCOMFORT 11 0.0029
147 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 8 0.0029
148 ORAL HERPES 56 0.0029
149 SKIN EXFOLIATION 241 0.0029
150 EOSINOPHILIA 50 0.0029
151 SLEEP TERROR 12 0.0028
152 PURULENT DISCHARGE 12 0.0028
153 DRY SKIN 374 0.0028
154 ANGINA UNSTABLE 18 0.0028
155 EYE PRURITUS 93 0.0028
156 TOOTH ABSCESS 28 0.0027
157 PRODUCT DOSE OMISSION ISSUE 807 0.0027
158 MAJOR DEPRESSION 20 0.0027
159 IMPAIRED GASTRIC EMPTYING 37 0.0027
160 SENSITIVE SKIN 20 0.0027
161 POOR VENOUS ACCESS 28 0.0027
162 RESPIRATORY TRACT INFECTION 70 0.0027
163 UPPER-AIRWAY COUGH SYNDROME 22 0.0027
164 EYE INFECTION 30 0.0027
165 DRUG EFFECT LESS THAN EXPECTED 39 0.0026
166 FOOT OPERATION 13 0.0026
167 REGURGITATION 9 0.0026
168 UPPER RESPIRATORY TRACT INFECTION 121 0.0026
169 HALLUCINATIONS, MIXED 11 0.0026
170 SEROTONIN SYNDROME 50 0.0026
171 INTENTIONAL DOSE OMISSION 74 0.0026
172 FOOD ALLERGY 20 0.0026
173 WEIGHT FLUCTUATION 27 0.0026
174 FEELING DRUNK 19 0.0026
175 HORDEOLUM 11 0.0025
176 END STAGE RENAL DISEASE 46 0.0025
177 TRISMUS 13 0.0025
178 WRONG PRODUCT ADMINISTERED 17 0.0025
179 ASTHMA 282 0.0025
180 FUNGAL SKIN INFECTION 10 0.0025
181 EXPOSURE VIA SKIN CONTACT 64 0.0025
182 SLEEP APNOEA SYNDROME 47 0.0025
183 ASPHYXIA 20 0.0024
184 SINUSITIS 250 0.0024
185 OSTEOPENIA 37 0.0024
186 RASH MACULO-PAPULAR 54 0.0024
187 WRIST FRACTURE 29 0.0024
188 RALES 14 0.0024
189 HAND FRACTURE 17 0.0024
190 CHRONIC KIDNEY DISEASE 182 0.0024
191 AUTISM SPECTRUM DISORDER 13 0.0024
192 TOOTH INFECTION 31 0.0023
193 DRY EYE 117 0.0023
194 STREPTOCOCCAL INFECTION 13 0.0023
195 TENSION HEADACHE 10 0.0023
196 CONCUSSION 18 0.0023
197 HIATUS HERNIA 30 0.0023
198 RHINOVIRUS INFECTION 9 0.0023
199 SKIN LACERATION 25 0.0023
200 AFFECTIVE DISORDER 18 0.0023
201 EYE PAIN 129 0.0023
202 PHOTOPHOBIA 43 0.0023
203 SOMNAMBULISM 15 0.0023
204 PNEUMONIA FUNGAL 9 0.0023
205 OCULAR HYPERAEMIA 108 0.0023
206 CONJUNCTIVITIS 42 0.0023
207 OESOPHAGEAL CANDIDIASIS 9 0.0023
208 CANDIDA INFECTION 38 0.0022
209 FACIAL PAIN 20 0.0022
210 MENINGITIS ASEPTIC 10 0.0022
211 HOMICIDAL IDEATION 9 0.0022
212 GASTROENTERITIS VIRAL 40 0.0022
213 BLOOD PRESSURE SYSTOLIC DECREASED 10 0.0022
214 VEIN DISORDER 11 0.0022
215 THERAPY PARTIAL RESPONDER 34 0.0022
216 SYMPTOM RECURRENCE 13 0.0022
217 PARKINSONISM 21 0.0022
218 ROSACEA 10 0.0021
219 EAR DISCOMFORT 22 0.0021
220 VAGINAL INFECTION 10 0.0021
221 TENDERNESS 22 0.0021
222 SKIN MASS 14 0.0021
223 URTICARIA 351 0.0021
224 SENSITIVITY TO WEATHER CHANGE 11 0.0021
225 DIABETES MELLITUS INADEQUATE CONTROL 37 0.0021
226 SKIN ATROPHY 12 0.0021
227 EXERCISE TOLERANCE DECREASED 12 0.0021
228 HYSTERECTOMY 18 0.0021
229 RESPIRATORY TRACT CONGESTION 33 0.0021
230 DERMATITIS ALLERGIC 26 0.0021
231 COMA 98 0.0021
232 ORAL CANDIDIASIS 27 0.0020
233 RASH PRURITIC 111 0.0020
234 PAIN IN JAW 58 0.0020
235 ECONOMIC PROBLEM 31 0.0020
236 INJECTION SITE DISCHARGE 11 0.0020
237 BRUXISM 11 0.0020
238 GINGIVITIS 11 0.0020
239 ERYTHEMA OF EYELID 11 0.0020
240 BRONCHITIS 150 0.0020
241 LOCALISED INFECTION 49 0.0020
242 LIGAMENT SPRAIN 20 0.0020
243 CHOLECYSTECTOMY 23 0.0020
244 MUSCULOSKELETAL CHEST PAIN 31 0.0020
245 ELECTROCARDIOGRAM QT PROLONGED 72 0.0020
246 IRON DEFICIENCY 9 0.0020
247 SURGERY 117 0.0020
248 COVID-19 349 0.0020
249 DENTAL CARIES 22 0.0020
250 PEMPHIGOID 15 0.0020
251 KIDNEY INFECTION 39 0.0020
252 THERAPEUTIC RESPONSE DECREASED 120 0.0020
253 TOXIC EPIDERMAL NECROLYSIS 30 0.0020
254 RASH MACULAR 69 0.0020
255 OSTEOPOROSIS 81 0.0020
256 HERNIA 38 0.0020
257 EYE IRRITATION 113 0.0020
258 MOTOR DYSFUNCTION 20 0.0020
259 EAR PAIN 38 0.0020
260 POOR QUALITY SLEEP 42 0.0019
261 ANHEDONIA 51 0.0019
262 OXYGEN SATURATION DECREASED 109 0.0019
263 EYE DISCHARGE 20 0.0019
264 POSTOPERATIVE WOUND INFECTION 13 0.0019
265 MUSCLE RIGIDITY 23 0.0019
266 RASH PUSTULAR 14 0.0019
267 ARTERIOSCLEROSIS 18 0.0019
268 PRODUCT USE IN UNAPPROVED INDICATION 474 0.0019
269 IRRITABLE BOWEL SYNDROME 41 0.0019
270 RASH 832 0.0019
271 OVARIAN CYST 19 0.0019
272 HYPERVENTILATION 11 0.0019
273 RIB FRACTURE 39 0.0019
274 ARTHROPOD BITE 14 0.0019
275 PRODUCTIVE COUGH 90 0.0019
276 FOREIGN BODY SENSATION IN EYES 12 0.0019
277 AORTIC VALVE INCOMPETENCE 8 0.0019
278 RESPIRATORY DEPRESSION 23 0.0019
279 HUMERUS FRACTURE 9 0.0019
280 COMPLICATION ASSOCIATED WITH DEVICE 27 0.0019
281 BLOOD UREA INCREASED 31 0.0018
282 PAPULE 13 0.0018
283 NERVE COMPRESSION 17 0.0018
284 HYPERTHERMIA 14 0.0018
285 VIRAL INFECTION 61 0.0018
286 THERMAL BURN 13 0.0018
287 MIGRAINE 174 0.0018
288 OBESITY 29 0.0018
289 SINUS DISORDER 36 0.0018
290 FULL BLOOD COUNT ABNORMAL 19 0.0018
291 SEDATION 47 0.0018
292 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 46 0.0018
293 GASTROINTESTINAL INFECTION 16 0.0018
294 PRODUCT LEAKAGE 10 0.0018
295 HYPERSOMNIA 51 0.0018
296 DYSPNOEA EXERTIONAL 67 0.0018
297 HEAVY MENSTRUAL BLEEDING 16 0.0018
298 INTENTIONAL OVERDOSE 114 0.0018
299 SINUS CONGESTION 24 0.0018
300 OROPHARYNGEAL DISCOMFORT 16 0.0018
301 BLOOD IRON DECREASED 21 0.0018
302 BACTERIAL INFECTION 33 0.0018
303 MIDDLE INSOMNIA 33 0.0018
304 INFLUENZA 197 0.0018
305 DECREASED ACTIVITY 19 0.0018
306 SCAB 20 0.0018
307 RESPIRATION ABNORMAL 12 0.0017
308 SKIN ULCER 45 0.0017
309 URINARY RETENTION 58 0.0017
310 THIRST 31 0.0017
311 MOUTH SWELLING 10 0.0017
312 POST PROCEDURAL INFECTION 14 0.0017
313 THERAPY INTERRUPTED 123 0.0017
314 MASS 24 0.0017
315 INABILITY TO AFFORD MEDICATION 17 0.0017
316 BLOOD LACTIC ACID INCREASED 9 0.0017
317 UPPER LIMB FRACTURE 34 0.0017
318 SPINAL OPERATION 21 0.0017
319 HYPOTONIA 17 0.0017
320 GASTROOESOPHAGEAL REFLUX DISEASE 137 0.0017
321 DISSOCIATION 13 0.0017
322 PULMONARY HYPERTENSION 35 0.0017
323 PRODUCT PREPARATION ISSUE 11 0.0017
324 HYPOGAMMAGLOBULINAEMIA 11 0.0017
325 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 13 0.0017
326 GRAFT VERSUS HOST DISEASE 12 0.0017
327 WALKING AID USER 11 0.0017
328 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 299 0.0017
329 LIMB INJURY 45 0.0017
330 BIPOLAR DISORDER 18 0.0017
331 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 17 0.0017
332 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 9 0.0017
333 RESTLESS LEGS SYNDROME 30 0.0016
334 CARPAL TUNNEL SYNDROME 23 0.0016
335 INFECTION 237 0.0016
336 ROTATOR CUFF SYNDROME 21 0.0016
337 FOOT FRACTURE 31 0.0016
338 HYPOPHOSPHATAEMIA 12 0.0016
339 BLOOD DISORDER 13 0.0016
340 DRUG DIVERSION 10 0.0016
341 PANIC ATTACK 59 0.0016
342 URINARY TRACT INFECTION 276 0.0016
343 NASAL CONGESTION 95 0.0016
344 POST PROCEDURAL COMPLICATION 31 0.0016
345 SCOLIOSIS 10 0.0016
346 LOWER LIMB FRACTURE 31 0.0016
347 COVID-19 PNEUMONIA 19 0.0016
348 BACK DISORDER 26 0.0016
349 RHINORRHOEA 103 0.0016
350 HYPOXIA 56 0.0016
351 LACRIMATION INCREASED 48 0.0016
352 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 76 0.0016
353 THERAPY NON-RESPONDER 71 0.0016
354 SCIATICA 25 0.0016
355 NEURALGIA 38 0.0016
356 EOSINOPHIL COUNT INCREASED 13 0.0016
357 BLOOD PRESSURE ABNORMAL 31 0.0016
358 TEMPERATURE INTOLERANCE 16 0.0015
359 DIZZINESS POSTURAL 15 0.0015
360 DRUG USE DISORDER 13 0.0015
361 FEAR OF INJECTION 11 0.0015
362 HERPES SIMPLEX 10 0.0015
363 PHARYNGITIS 19 0.0015
364 ALTERED STATE OF CONSCIOUSNESS 33 0.0015
365 INCREASED TENDENCY TO BRUISE 14 0.0015
366 INJECTION SITE DISCOMFORT 16 0.0015
367 VITAMIN D DECREASED 13 0.0015
368 DERMATITIS BULLOUS 11 0.0015
369 MALNUTRITION 17 0.0015
370 PRODUCT DISPENSING ERROR 33 0.0015
371 INTERVERTEBRAL DISC DEGENERATION 14 0.0015
372 OEDEMA 82 0.0015
373 INTERVERTEBRAL DISC PROTRUSION 33 0.0015
374 ACUTE RESPIRATORY FAILURE 29 0.0015
375 CYSTITIS 48 0.0015
376 ORAL DISORDER 11 0.0015
377 MELAENA 33 0.0015
378 QUALITY OF LIFE DECREASED 20 0.0015
379 RHINITIS 12 0.0015
380 LIMB DISCOMFORT 46 0.0015
381 ANKLE FRACTURE 23 0.0015
382 BLOOD SODIUM DECREASED 28 0.0015
383 LEUKAEMIA 14 0.0015
384 ANXIETY 422 0.0015
385 MYDRIASIS 19 0.0015
386 BEHAVIOUR DISORDER 8 0.0015
387 FUNGAL INFECTION 49 0.0015
388 COUGH 412 0.0015
389 DYSURIA 54 0.0015
390 MENISCUS INJURY 9 0.0015
391 BLOOD POTASSIUM DECREASED 44 0.0015
392 ASTHENOPIA 8 0.0015
393 STAPHYLOCOCCAL INFECTION 48 0.0015
394 PHOTOSENSITIVITY REACTION 24 0.0015
395 EYE SWELLING 54 0.0015
396 TOOTH FRACTURE 16 0.0014
397 SOMNOLENCE 292 0.0014
398 ULCER 23 0.0014
399 ANAL INCONTINENCE 13 0.0014
400 PNEUMONIA ASPIRATION 36 0.0014
401 FIBROMYALGIA 35 0.0014
402 NEPHROLITHIASIS 66 0.0014
403 OBSTRUCTIVE AIRWAYS DISORDER 16 0.0014
404 PETECHIAE 15 0.0014
405 FEELING COLD 40 0.0014
406 LEUKOCYTOSIS 26 0.0014
407 ORTHOSTATIC HYPOTENSION 25 0.0014
408 BACTERAEMIA 17 0.0014
409 RENAL TUBULAR NECROSIS 14 0.0014
410 SNEEZING 32 0.0014
411 VITREOUS FLOATERS 14 0.0014
412 HYPONATRAEMIA 80 0.0014
413 APHTHOUS ULCER 11 0.0014
414 PNEUMONIA BACTERIAL 13 0.0014
415 NASOPHARYNGITIS 260 0.0014
416 PERIPHERAL SWELLING 217 0.0014
417 CARDIOGENIC SHOCK 20 0.0014
418 FURUNCLE 11 0.0014
419 PLATELET COUNT INCREASED 18 0.0014
420 MENTAL DISORDER 60 0.0014
421 VERTIGO 84 0.0014
422 SUICIDAL IDEATION 126 0.0014
423 GROIN PAIN 12 0.0014
424 SPINAL OSTEOARTHRITIS 12 0.0014
425 HUNGER 19 0.0014
426 EYE INFLAMMATION 13 0.0014
427 RETCHING 29 0.0014
428 SECRETION DISCHARGE 17 0.0014
429 HYPOTENSION 272 0.0014
430 CEREBRAL DISORDER 10 0.0014
431 SKIN DISCOLOURATION 62 0.0013
432 GAIT INABILITY 45 0.0013
433 SWELLING 126 0.0013
434 ACCIDENT 16 0.0013
435 RASH PAPULAR 30 0.0013
436 ESCHERICHIA INFECTION 11 0.0013
437 THROAT IRRITATION 60 0.0013
438 PAIN OF SKIN 36 0.0013
439 BLISTER 75 0.0013
440 NIGHT SWEATS 43 0.0013
441 PRODUCT USE COMPLAINT 21 0.0013
442 PSORIATIC ARTHROPATHY 54 0.0013
443 OROPHARYNGEAL PAIN 123 0.0013
444 HEAD INJURY 42 0.0013
445 INJECTION SITE PAIN 407 0.0013
446 TACHYCARDIA 117 0.0013
447 HEADACHE 824 0.0013
448 BLOOD PRESSURE DECREASED 87 0.0013
449 ACIDOSIS 10 0.0013
450 BOWEL MOVEMENT IRREGULARITY 10 0.0013
451 SUICIDE ATTEMPT 79 0.0013
452 HAIR GROWTH ABNORMAL 9 0.0013
453 UNINTENTIONAL MEDICAL DEVICE REMOVAL 15 0.0013
454 RED BLOOD CELL COUNT DECREASED 37 0.0013
455 ACUTE KIDNEY INJURY 198 0.0013
456 LIP SWELLING 43 0.0013
457 TOXIC SKIN ERUPTION 13 0.0013
458 FACIAL PARALYSIS 11 0.0013
459 BRONCHOPULMONARY ASPERGILLOSIS 10 0.0013
460 APHONIA 18 0.0013
461 HEPATIC STEATOSIS 24 0.0013
462 VASCULITIS 15 0.0013
463 BACK INJURY 14 0.0013
464 TINNITUS 59 0.0013
465 GASTROINTESTINAL DISORDER 115 0.0013
466 FEEDING DISORDER 26 0.0013
467 FLANK PAIN 12 0.0013
468 DRY THROAT 13 0.0013
469 GASTROINTESTINAL INFLAMMATION 10 0.0013
470 TORSADE DE POINTES 10 0.0013
471 DYSPHONIA 74 0.0013
472 SEPSIS 141 0.0013
473 JOINT INJURY 27 0.0013
474 COGNITIVE DISORDER 59 0.0013
475 GAMMA-GLUTAMYLTRANSFERASE INCREASED 28 0.0013
476 VENTRICULAR FIBRILLATION 14 0.0013
477 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 12 0.0013
478 HYPERLIPIDAEMIA 15 0.0013
479 DEMENTIA 35 0.0013
480 CHOLESTASIS 24 0.0012
481 INTENTIONAL PRODUCT USE ISSUE 109 0.0012
482 PURPURA 11 0.0012
483 HEART RATE INCREASED 123 0.0012
484 INJECTION SITE SWELLING 95 0.0012
485 PRESYNCOPE 30 0.0012
486 FALL 410 0.0012
487 AUTOIMMUNE DISORDER 12 0.0012
488 BACK PAIN 286 0.0012
489 SKIN DISORDER 41 0.0012
490 DECUBITUS ULCER 10 0.0012
491 SCAR 21 0.0012
492 RENAL PAIN 13 0.0012
493 DEPRESSION 279 0.0012
494 HYPERKALAEMIA 43 0.0012
495 COELIAC DISEASE 12 0.0012
496 ORAL DISCOMFORT 17 0.0012
497 ENCEPHALOPATHY 30 0.0012
498 ERYTHEMA 251 0.0012
499 CARDIOMEGALY 15 0.0012
500 TYPE 2 DIABETES MELLITUS 41 0.0012
501 NECK PAIN 68 0.0012
502 AMNESIA 79 0.0012
503 SARS-COV-2 TEST POSITIVE 16 0.0012
504 PAIN 744 0.0012
505 HERPES ZOSTER 69 0.0012
506 INJECTION SITE DISCOLOURATION 15 0.0012
507 FLUID RETENTION 61 0.0012
508 PNEUMOTHORAX 19 0.0012
509 HALLUCINATION, AUDITORY 19 0.0012
510 SPLENOMEGALY 14 0.0012
511 DIPLOPIA 31 0.0012
512 PNEUMONIA 386 0.0012
513 CHEST DISCOMFORT 122 0.0012
514 PYREXIA 412 0.0012
515 HYPERSENSITIVITY 221 0.0012
516 EMPHYSEMA 12 0.0012
517 PRODUCT AVAILABILITY ISSUE 27 0.0012
518 HYPOTHERMIA 12 0.0012
519 BURNING SENSATION 83 0.0012
520 THROAT TIGHTNESS 32 0.0012
521 JOINT STIFFNESS 31 0.0012
522 DELIRIUM 41 0.0012
523 HYPERGLYCAEMIA 43 0.0012
524 VOMITING 554 0.0012
525 CONDITION AGGRAVATED 358 0.0012
526 CHEST PAIN 218 0.0012
527 SLUGGISHNESS 12 0.0012
528 DEVICE PHYSICAL PROPERTY ISSUE 9 0.0012
529 ABDOMINAL DISCOMFORT 197 0.0012
530 PROCEDURAL COMPLICATION 9 0.0012
531 PULMONARY ARTERIAL HYPERTENSION 17 0.0012
532 NEUTROPHIL COUNT INCREASED 12 0.0012
533 BLOOD PRESSURE INCREASED 179 0.0012
534 BLOOD POTASSIUM INCREASED 19 0.0012
535 GASTROENTERITIS 17 0.0012
536 TOOTHACHE 21 0.0012
537 BLOOD URINE PRESENT 22 0.0012
538 HYPERBILIRUBINAEMIA 12 0.0012
539 LYMPHADENOPATHY 41 0.0012
540 CORONARY ARTERY DISEASE 35 0.0012
541 PROCEDURAL PAIN 32 0.0012
542 MENTAL STATUS CHANGES 32 0.0012
543 RASH ERYTHEMATOUS 55 0.0011
544 REBOUND EFFECT 13 0.0011
545 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 60 0.0011
546 HYPOKALAEMIA 53 0.0011
547 SPINAL FRACTURE 23 0.0011
548 ROAD TRAFFIC ACCIDENT 48 0.0011
549 CLOSTRIDIUM DIFFICILE INFECTION 25 0.0011
550 INSOMNIA 305 0.0011
551 URINE OUTPUT DECREASED 10 0.0011
552 GASTRITIS 30 0.0011
553 INTENTIONAL SELF-INJURY 23 0.0011
554 DEPRESSED LEVEL OF CONSCIOUSNESS 45 0.0011
555 COLD SWEAT 20 0.0011
556 BLOOD ALBUMIN DECREASED 9 0.0011
557 IMMUNOSUPPRESSION 10 0.0011
558 TRICUSPID VALVE INCOMPETENCE 9 0.0011
559 CELLULITIS 57 0.0011
560 GINGIVAL PAIN 9 0.0011
561 SKIN LESION 31 0.0011
562 AGRANULOCYTOSIS 21 0.0011
563 WHEEZING 67 0.0011
564 CRYING 41 0.0011
565 SINUS TACHYCARDIA 16 0.0011
566 ILEUS 14 0.0011
567 TOOTH EXTRACTION 14 0.0011
568 PRODUCT USE ISSUE 211 0.0011
569 ANAPHYLACTIC REACTION 62 0.0011
570 OBSESSIVE-COMPULSIVE DISORDER 9 0.0011
571 DECREASED IMMUNE RESPONSIVENESS 11 0.0011
572 WHITE BLOOD CELL COUNT INCREASED 43 0.0011
573 INJECTION SITE REACTION 77 0.0011
574 ELECTROLYTE IMBALANCE 13 0.0011
575 INJECTION SITE BRUISING 89 0.0011
576 GOUT 20 0.0011
577 WEIGHT DECREASED 311 0.0011
578 FRUSTRATION TOLERANCE DECREASED 9 0.0011
579 HOSPICE CARE 11 0.0011
580 HIP ARTHROPLASTY 17 0.0011
581 CONSTIPATION 242 0.0011
582 DRY MOUTH 90 0.0011
583 NAUSEA 877 0.0011
584 ANGIOEDEMA 49 0.0011
585 FATIGUE 862 0.0011
586 LIP DRY 10 0.0011
587 SYNCOPE 110 0.0011
588 HYPOPHAGIA 28 0.0011
589 FEELING HOT 67 0.0011
590 SKIN IRRITATION 50 0.0011
591 CONTUSION 105 0.0011
592 TREMOR 181 0.0011
593 SPINAL COMPRESSION FRACTURE 9 0.0011
594 PRODUCT ADMINISTRATION ERROR 22 0.0011
595 INTESTINAL OBSTRUCTION 41 0.0011
596 RENAL FAILURE 144 0.0011
597 TASTE DISORDER 22 0.0011
598 BLOOD PRESSURE FLUCTUATION 26 0.0011
599 PERICARDIAL EFFUSION 25 0.0011
600 EATING DISORDER 23 0.0011
601 TOOTH DISORDER 24 0.0011
602 NERVE INJURY 12 0.0011
603 ACUTE RESPIRATORY DISTRESS SYNDROME 19 0.0011
604 PULMONARY MASS 16 0.0011
605 IMMUNODEFICIENCY 16 0.0011
606 FACE OEDEMA 18 0.0011
607 HYPERTENSION 226 0.0011
608 ACCIDENTAL OVERDOSE 39 0.0011
609 GALLBLADDER DISORDER 19 0.0011
610 IMMUNE SYSTEM DISORDER 14 0.0011
611 AGITATION 78 0.0011
612 INCORRECT PRODUCT ADMINISTRATION DURATION 23 0.0011
613 TREATMENT NONCOMPLIANCE 58 0.0011
614 SPINAL DISORDER 10 0.0011
615 DYSPNOEA 597 0.0011
616 ARTHRALGIA 438 0.0011
617 GASTRIC ULCER 20 0.0011
618 DEHYDRATION 140 0.0010
619 MUSCULOSKELETAL DISCOMFORT 18 0.0010
620 KNEE ARTHROPLASTY 22 0.0010
621 SUPRAVENTRICULAR TACHYCARDIA 10 0.0010
622 NEOPLASM 12 0.0010
623 MOBILITY DECREASED 75 0.0010
624 DYSPHAGIA 99 0.0010
625 HALLUCINATION, VISUAL 22 0.0010
626 MUSCLE TWITCHING 24 0.0010
627 MEMORY IMPAIRMENT 143 0.0010
628 CARDIAC MURMUR 9 0.0010
629 DEVICE RELATED INFECTION 16 0.0010
630 CLOSTRIDIUM DIFFICILE COLITIS 11 0.0010
631 DYSARTHRIA 39 0.0010
632 STEVENS-JOHNSON SYNDROME 23 0.0010
633 DECREASED APPETITE 240 0.0010
634 HYPERHIDROSIS 133 0.0010
635 WEIGHT INCREASED 231 0.0010
636 POLLAKIURIA 43 0.0010
637 CARDIAC ARREST 85 0.0010
638 VENTRICULAR TACHYCARDIA 17 0.0010
639 NAIL DISORDER 9 0.0010
640 APNOEA 8 0.0010
641 HAEMORRHOIDS 20 0.0010
642 ABDOMINAL PAIN UPPER 211 0.0010
643 BONE PAIN 60 0.0010
644 PANCREATITIS ACUTE 23 0.0010
645 STOMATITIS 62 0.0010
646 VISION BLURRED 140 0.0010
647 PSORIASIS 133 0.0010
648 CYANOSIS 16 0.0010
649 KNEE OPERATION 10 0.0010
650 DIZZINESS 507 0.0010
651 DYSPEPSIA 100 0.0010
652 RESPIRATORY ARREST 28 0.0010
653 FAECES DISCOLOURED 22 0.0010
654 DISABILITY 20 0.0010
655 INJECTION SITE RASH 31 0.0010
656 DRUG INTERACTION 160 0.0010
657 INTENTIONAL PRODUCT MISUSE 88 0.0010
658 WOUND INFECTION 11 0.0010
659 SEIZURE 116 0.0010
660 FEMUR FRACTURE 31 0.0010
661 INJECTION SITE PRURITUS 67 0.0010
662 HALLUCINATION 75 0.0010
663 DISSEMINATED INTRAVASCULAR COAGULATION 14 0.0010
664 PALPITATIONS 116 0.0010
665 ABDOMINAL PAIN 230 0.0010
666 NOCTURIA 12 0.0010
667 HIDRADENITIS 9 0.0010
668 ASCITES 29 0.0010
669 EXOSTOSIS 9 0.0010
670 DIARRHOEA 636 0.0010
671 EYELID PTOSIS 10 0.0010
672 DISTURBANCE IN ATTENTION 53 0.0010
673 PULMONARY OEDEMA 44 0.0010
674 HOT FLUSH 74 0.0010
675 LUNG DISORDER 48 0.0010
676 INJECTION SITE URTICARIA 24 0.0010
677 MUSCULAR WEAKNESS 111 0.0010
678 MUSCLE SPASTICITY 12 0.0010
679 IRON DEFICIENCY ANAEMIA 9 0.0010
680 CATARACT 58 0.0010
681 BALANCE DISORDER 84 0.0010
682 HYPOTHYROIDISM 31 0.0010
683 HYPOGLYCAEMIA 47 0.0010
684 PAIN IN EXTREMITY 285 0.0010
685 GENERALISED TONIC-CLONIC SEIZURE 16 0.0010
686 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 53 0.0010
687 HEPATIC ENCEPHALOPATHY 9 0.0010
688 HYPOKINESIA 14 0.0010
689 CHILLS 113 0.0010
690 NEPHROPATHY 9 0.0010
691 MICTURITION URGENCY 11 0.0010
692 VENTRICULAR EXTRASYSTOLES 10 0.0010
693 TUBULOINTERSTITIAL NEPHRITIS 18 0.0010
694 ASPARTATE AMINOTRANSFERASE INCREASED 51 0.0010
695 FEELING ABNORMAL 230 0.0010
696 PSYCHOTIC DISORDER 28 0.0009
697 URINARY INCONTINENCE 28 0.0009
698 EYE DISORDER 31 0.0009
699 RENAL INJURY 28 0.0009
700 ANGINA PECTORIS 27 0.0009
701 INCREASED APPETITE 18 0.0009
702 OSTEOMYELITIS 17 0.0009
703 DIVERTICULITIS 26 0.0009
704 ORAL PAIN 21 0.0009
705 MALAISE 411 0.0009
706 INFUSION RELATED REACTION 62 0.0009
707 SENSORY DISTURBANCE 15 0.0009
708 HOSPITALISATION 143 0.0009
709 WOUND 26 0.0009
710 UNRESPONSIVE TO STIMULI 24 0.0009
711 DYSTONIA 18 0.0009
712 SKIN BURNING SENSATION 66 0.0009
713 TRANSIENT ISCHAEMIC ATTACK 31 0.0009
714 PULMONARY THROMBOSIS 10 0.0009
715 ARTHRITIS 72 0.0009
716 ASPIRATION 10 0.0009
717 DRUG INTOLERANCE 88 0.0009
718 DEPRESSED MOOD 48 0.0009
719 NEUTROPHIL COUNT DECREASED 37 0.0009
720 THROMBOSIS 73 0.0009
721 HEAD DISCOMFORT 16 0.0009
722 DRUG ERUPTION 16 0.0009
723 ABDOMINAL DISTENSION 94 0.0009
724 NIGHTMARE 31 0.0009
725 PERICARDITIS 15 0.0009
726 PANCREATITIS 47 0.0009
727 GENERALISED OEDEMA 11 0.0009
728 CYST 11 0.0009
729 HEART RATE DECREASED 31 0.0009
730 MUSCLE SPASMS 162 0.0009
731 GLAUCOMA 17 0.0009
732 EPISTAXIS 66 0.0009
733 MEDICATION ERROR 49 0.0009
734 LABORATORY TEST ABNORMAL 26 0.0009
735 BLOOD CHOLESTEROL INCREASED 41 0.0009
736 MYALGIA 149 0.0009
737 PRODUCT PREPARATION ERROR 18 0.0009
738 METABOLIC ACIDOSIS 28 0.0009
739 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 15 0.0009
740 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 62 0.0009
741 RESPIRATORY DISTRESS 24 0.0009
742 BRADYCARDIA 46 0.0009
743 INJECTION SITE IRRITATION 11 0.0009
744 MUSCLE TIGHTNESS 14 0.0009
745 ALANINE AMINOTRANSFERASE INCREASED 53 0.0009
746 FOLLICULITIS 9 0.0009
747 MOUTH ULCERATION 18 0.0009
748 MULTIPLE FRACTURES 14 0.0009
749 HEPATIC CIRRHOSIS 16 0.0009
750 OSTEOARTHRITIS 36 0.0008
751 BLOOD TRIGLYCERIDES INCREASED 15 0.0008
752 HYPOAESTHESIA 127 0.0008
753 INJECTION SITE INDURATION 11 0.0008
754 HEPATOCELLULAR INJURY 12 0.0008
755 FLUSHING 86 0.0008
756 BLOOD ALKALINE PHOSPHATASE INCREASED 21 0.0008
757 THYROID DISORDER 13 0.0008
758 ASTHENIA 317 0.0008
759 LOSS OF CONSCIOUSNESS 108 0.0008
760 SPEECH DISORDER 44 0.0008
761 CHOLECYSTITIS 10 0.0008
762 RHABDOMYOLYSIS 35 0.0008
763 LIVER FUNCTION TEST INCREASED 18 0.0008
764 INJECTION SITE MASS 31 0.0008
765 PULMONARY CONGESTION 11 0.0008
766 LIVER DISORDER 37 0.0008
767 INFLAMMATION 43 0.0008
768 SWELLING FACE 54 0.0008
769 ANOSMIA 12 0.0008
770 PLATELET COUNT DECREASED 88 0.0008
771 ANAEMIA 157 0.0008
772 CONFUSIONAL STATE 133 0.0008
773 LETHARGY 47 0.0008
774 ANAPHYLACTIC SHOCK 21 0.0008
775 BLOOD BILIRUBIN INCREASED 22 0.0008
776 OEDEMA PERIPHERAL 99 0.0008
777 MULTIPLE ORGAN DYSFUNCTION SYNDROME 23 0.0008
778 FLATULENCE 46 0.0008
779 DISORIENTATION 32 0.0008
780 BLADDER DISORDER 8 0.0008
781 GINGIVAL BLEEDING 11 0.0008
782 DEVICE DISLOCATION 35 0.0008
783 NERVOUS SYSTEM DISORDER 25 0.0008
784 DEEP VEIN THROMBOSIS 52 0.0008
785 OFF LABEL USE 698 0.0008
786 ABNORMAL DREAMS 22 0.0008
787 MITRAL VALVE INCOMPETENCE 9 0.0008
788 RENAL DISORDER 37 0.0008
789 FULL BLOOD COUNT DECREASED 16 0.0008
790 BRAIN OEDEMA 10 0.0008
791 VISUAL IMPAIRMENT 98 0.0008
792 ILL-DEFINED DISORDER 48 0.0008
793 NEEDLE ISSUE 23 0.0008
794 DEVICE FAILURE 12 0.0008
795 DYSSTASIA 23 0.0008
796 FEELING JITTERY 15 0.0008
797 MENTAL IMPAIRMENT 19 0.0008
798 DRUG INEFFECTIVE 1033 0.0008
799 PSYCHOMOTOR HYPERACTIVITY 13 0.0008
800 BLOOD TEST ABNORMAL 11 0.0008
801 PRODUCT PRESCRIBING ISSUE 17 0.0008
802 AGGRESSION 39 0.0008
803 METASTASES TO LUNG 9 0.0008
804 EMOTIONAL DISORDER 24 0.0008
805 NEUROPATHY PERIPHERAL 74 0.0008
806 TENDONITIS 12 0.0008
807 BRONCHOSPASM 11 0.0008
808 RESPIRATORY DISORDER 23 0.0008
809 SUBDURAL HAEMATOMA 11 0.0008
810 SPINAL PAIN 9 0.0008
811 ACCIDENTAL EXPOSURE TO PRODUCT 79 0.0008
812 DIABETES MELLITUS 58 0.0008
813 CARDIAC DISORDER 71 0.0008
814 PLEURAL EFFUSION 46 0.0008
815 PRODUCT PRESCRIBING ERROR 18 0.0008
816 APATHY 11 0.0008
817 PARANOIA 13 0.0008
818 ALOPECIA 148 0.0008
819 UNEVALUABLE EVENT 57 0.0008
820 INFLUENZA LIKE ILLNESS 62 0.0008
821 ABSCESS 12 0.0008
822 POLYNEUROPATHY 9 0.0008
823 GAIT DISTURBANCE 143 0.0007
824 NERVOUSNESS 39 0.0007
825 JAUNDICE 20 0.0007
826 DEVICE USE ISSUE 13 0.0007
827 EXTRA DOSE ADMINISTERED 30 0.0007
828 TACHYPNOEA 10 0.0007
829 BODY TEMPERATURE INCREASED 15 0.0007
830 SYSTEMIC LUPUS ERYTHEMATOSUS 26 0.0007
831 MANIA 12 0.0007
832 WHITE BLOOD CELL COUNT DECREASED 79 0.0007
833 TOOTH LOSS 15 0.0007
834 MUSCULOSKELETAL STIFFNESS 63 0.0007
835 PARAESTHESIA 113 0.0007
836 HYPOMAGNESAEMIA 10 0.0007
837 BLOOD PRESSURE SYSTOLIC INCREASED 14 0.0007
838 RESPIRATORY FAILURE 52 0.0007
839 COLITIS 27 0.0007
840 CARDIAC FAILURE 57 0.0007
841 CHROMATURIA 16 0.0007
842 THINKING ABNORMAL 13 0.0007
843 HEPATIC FUNCTION ABNORMAL 26 0.0007
844 BLOOD LACTATE DEHYDROGENASE INCREASED 11 0.0007
845 BEDRIDDEN 9 0.0007
846 DYSMENORRHOEA 9 0.0007
847 FEBRILE NEUTROPENIA 45 0.0007
848 EYE HAEMORRHAGE 9 0.0007
849 SWOLLEN TONGUE 21 0.0007
850 HAEMATEMESIS 17 0.0007
851 BONE DENSITY DECREASED 21 0.0007
852 THERAPEUTIC PRODUCT EFFECT DECREASED 30 0.0007
853 ATRIAL FIBRILLATION 65 0.0007
854 CHOKING 13 0.0007
855 DRUG LEVEL INCREASED 11 0.0007
856 HEART RATE IRREGULAR 15 0.0007
857 BLINDNESS 27 0.0007
858 PALLOR 18 0.0007
859 CONTRAINDICATED PRODUCT ADMINISTERED 20 0.0007
860 HEPATIC ENZYME INCREASED 45 0.0007
861 MOOD ALTERED 18 0.0007
862 LIVER FUNCTION TEST ABNORMAL 19 0.0007
863 DELUSION 10 0.0006
864 AGEUSIA 16 0.0006
865 EMOTIONAL DISTRESS 77 0.0006
866 ADVERSE DRUG REACTION 57 0.0006
867 OVERDOSE 136 0.0006
868 PARALYSIS 9 0.0006
869 THROMBOCYTOPENIA 70 0.0006
870 THERAPEUTIC RESPONSE UNEXPECTED 28 0.0006
871 INCORRECT DOSE ADMINISTERED 142 0.0006
872 HIP FRACTURE 20 0.0006
873 PRESCRIBED OVERDOSE 12 0.0006
874 WITHDRAWAL SYNDROME 26 0.0006
875 IRRITABILITY 37 0.0006
876 INJECTION SITE ERYTHEMA 76 0.0006
877 SHOCK 14 0.0006
878 HYPOACUSIS 26 0.0006
879 ADVERSE REACTION 8 0.0006
880 RESTLESSNESS 22 0.0006
881 SEPTIC SHOCK 26 0.0006
882 APHASIA 18 0.0006
883 ACNE 45 0.0006
884 BONE MARROW FAILURE 12 0.0006
885 CARDIAC FAILURE CONGESTIVE 47 0.0006
886 NEOPLASM MALIGNANT 39 0.0006
887 CHOLELITHIASIS 19 0.0006
888 IMPAIRED HEALING 19 0.0006
889 BASAL CELL CARCINOMA 9 0.0006
890 DEAFNESS 15 0.0006
891 JOINT SWELLING 69 0.0006
892 SYRINGE ISSUE 10 0.0006
893 RENAL IMPAIRMENT 48 0.0006
894 HEPATIC FAILURE 17 0.0006
895 ANGER 19 0.0006
896 IMPAIRED WORK ABILITY 12 0.0006
897 HAEMATOCRIT DECREASED 11 0.0006
898 PANCYTOPENIA 31 0.0006
899 PRESCRIBED UNDERDOSE 11 0.0006
900 BLOOD CREATININE INCREASED 36 0.0006
901 PELVIC PAIN 10 0.0005
902 BONE DISORDER 10 0.0005
903 HAEMORRHAGE 57 0.0005
904 MULTIPLE SCLEROSIS 26 0.0005
905 HAEMATOCHEZIA 30 0.0005
906 ACUTE MYOCARDIAL INFARCTION 16 0.0005
907 BLOOD GLUCOSE DECREASED 26 0.0005
908 COAGULOPATHY 9 0.0005
909 HAEMOPTYSIS 15 0.0005
910 MYOCARDIAL INFARCTION 93 0.0005
911 MOVEMENT DISORDER 17 0.0005
912 HYPOCALCAEMIA 10 0.0005
913 EPILEPSY 16 0.0005
914 DEVICE DEFECTIVE 9 0.0005
915 NEOPLASM PROGRESSION 18 0.0005
916 DEVICE BREAKAGE 21 0.0005
917 DYSKINESIA 21 0.0005
918 HAEMOGLOBIN DECREASED 53 0.0005
919 MATERNAL EXPOSURE DURING PREGNANCY 46 0.0005
920 SKIN CANCER 11 0.0005
921 UNDERDOSE 37 0.0005
922 ARRHYTHMIA 24 0.0005
923 ABNORMAL BEHAVIOUR 20 0.0005
924 TARDIVE DYSKINESIA 14 0.0005
925 GASTRIC DISORDER 17 0.0005
926 C-REACTIVE PROTEIN INCREASED 18 0.0005
927 GENERAL PHYSICAL HEALTH DETERIORATION 57 0.0005
928 GLOSSODYNIA 11 0.0005
929 BLOOD CREATINE PHOSPHOKINASE INCREASED 14 0.0005
930 FEAR 13 0.0005
931 PNEUMONITIS 13 0.0005
932 RHEUMATOID ARTHRITIS 54 0.0005
933 GLYCOSYLATED HAEMOGLOBIN INCREASED 12 0.0005
934 RENAL FAILURE ACUTE 20 0.0005
935 MOOD SWINGS 15 0.0005
936 RECTAL HAEMORRHAGE 20 0.0005
937 DISEASE RECURRENCE 22 0.0005
938 DEVICE ISSUE 41 0.0005
939 CEREBROVASCULAR ACCIDENT 77 0.0005
940 MULTIPLE SCLEROSIS RELAPSE 31 0.0005
941 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 90 0.0004
942 PULMONARY EMBOLISM 42 0.0004
943 INJECTION SITE HAEMORRHAGE 35 0.0004
944 DEVICE LEAKAGE 19 0.0004
945 LUNG NEOPLASM MALIGNANT 18 0.0004
946 ADVERSE EVENT 40 0.0004
947 ARTHROPATHY 24 0.0004
948 INJURY 30 0.0004
949 OSTEONECROSIS 14 0.0004
950 NEUTROPENIA 57 0.0004
951 EXPOSURE DURING PREGNANCY 26 0.0004
952 PRURITUS GENERALISED 9 0.0004
953 TREATMENT FAILURE 34 0.0004
954 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 19 0.0004
955 HEPATOTOXICITY 9 0.0004
956 DEVICE MALFUNCTION 28 0.0004
957 ABDOMINAL PAIN LOWER 10 0.0004
958 GASTROINTESTINAL HAEMORRHAGE 33 0.0004
959 INTERSTITIAL LUNG DISEASE 19 0.0004
960 DRUG DEPENDENCE 59 0.0004
961 ABASIA 9 0.0004
962 VISUAL ACUITY REDUCED 12 0.0004
963 EXPIRED PRODUCT ADMINISTERED 12 0.0004
964 ERECTILE DYSFUNCTION 9 0.0004
965 DEATH 299 0.0003
966 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 10 0.0003
967 PRODUCT ADHESION ISSUE 12 0.0003
968 THERAPY CESSATION 17 0.0003
969 MUSCULOSKELETAL PAIN 17 0.0003
970 ABORTION SPONTANEOUS 13 0.0003
971 DYSGEUSIA 24 0.0003
972 NO ADVERSE EVENT 58 0.0003
973 BLOOD GLUCOSE INCREASED 60 0.0003
974 LEUKOPENIA 15 0.0003
975 CONVULSION 17 0.0003
976 FOETAL EXPOSURE DURING PREGNANCY 24 0.0003
977 HAEMATURIA 10 0.0003
978 COLITIS ULCERATIVE 13 0.0003
979 DEVICE USE ERROR 10 0.0003
980 DEVICE DIFFICULT TO USE 19 0.0003
981 LOWER RESPIRATORY TRACT INFECTION 13 0.0003
982 DRUG WITHDRAWAL SYNDROME 25 0.0003
983 DISEASE PROGRESSION 33 0.0003
984 LACTIC ACIDOSIS 9 0.0003
985 PRODUCT STORAGE ERROR 24 0.0003
986 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 9 0.0003
987 PRODUCT DOSE OMISSION 15 0.0002
988 PRODUCT SUBSTITUTION ISSUE 13 0.0002
989 BREAST CANCER 21 0.0002
990 MALIGNANT NEOPLASM PROGRESSION 19 0.0002
991 PRODUCT QUALITY ISSUE 25 0.0002
992 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 11 0.0002
993 DRUG DOSE OMISSION 24 0.0001